Report
Jonathan Moreland
EUR 9.04 For Business Accounts Only

InsiderInsights Daily Ratings Report: July 12, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
Collegium Pharmaceutical Inc.

Collegium Pharmaceuticals is a pharmaceutical company focused on pain management. The company's lead product, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the U.S. Food and Drug Administration for the management of pain. The company's product portfolio also includes Nucynta ER, an extended-release formulation of tapentadol for the management of pain including neuropathic pain associated with diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate-release formulation of tapentadol that is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults.

Libbey Inc.

Libbey is engaged in the design, production and sale of tableware and other products. The company's products include glassware products, glass tableware, ceramicware, metalware and other tabletop products. Glass tableware products include products such as tumblers, stemware, mugs, bowls, vases, salt and pepper shakers, shot glasses, canisters, candleholders and other items. Other glass products include storageware, serveware, bakeware, handmade glass tableware and components such as blender jars and mixing bowls sold to original equipment manufacturers. The company also provides a range of ceramic dinnerware products. These include plates, bowls, platters, cups, saucers and other tabletop accessories.

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch